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Background: Schistosomiasis remains a serious public health problem in affected countries, and routine, highly
sensitive and cost-effective diagnostic methods are lacking. We evaluated two immunodiagnostic techniques for
the detection of Schistosoma japonicum infections: circulating antibody and circulating antigen assays.
Methods: A total of 1864 individuals (between 6 and 72 years old) residing in five administrative villages in
Hubei province were screened by serum examination with an indirect hemagglutination assay (IHA). The positive
individuals (titer ≥20 in IHA) were reconfirmed by stool examination with the Kato-Katz method (three slides
from a single stool specimen). Samples of good serum quality and a volume above 0.5 ml were selected for further
testing with two immunodiagnostic antibody (DDIA and ELISA) and two antigen (ELISA) assays.
Results: The average antibody positive rate in the five villages was 12.7%, while the average parasitological
prevalence was 1.50%; 25 of the 28 egg-positive samples were also circulating antigen-positive. Significant
differences were observed between the prevalence according to the Kato-Katz method and all three immunodiagnostic
antibody assays (P-value <0.0001). Similar differences were observed between the Kato-Katz method and the two
immunodiagnostic antigen assays (P-value <0.0001) and between the antigen and antibody assays (P-value <0.0001).
Conclusion: Both circulating antibody and circulating antigen assays had acceptable performance characteristics.
Immunodiagnostic techniques to detect circulating antigens have potential to be deployed for schistosomiasis
japonica screening in the endemic areas.
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Schistosomiasis remains a serious public health problem in
endemic countries [1-3], including in the People’s Republic
of China. According to the national annual disease report,
there were 365,770 Schistosoma japonicum patients
and approximately 250 million people at risk of infec-
tion in China in 2009 [4]. After a half-century fight* Correspondence: chenjiaxu1962@163.com
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sity of S. japonicum infection have decreased significantly
[5-8]. Today, the prevalence is relatively low in most of
the traditional endemic areas. Therefore, cost-effective
routine methods for diagnosis are now required for
deployment in low-endemic areas and for the correct
diagnosis of infections in travelers and migrants
[9-11]. Currently available diagnostic methods include
direct parasitological (parasite egg detection and miracid-
ium hatching), direct serological (circulating antigens) and
indirect serological techniques (circulating antibodies).
Microscopic examination of stool is traditionally considered. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[12]. However, the involved procedures (mainly Kato-
Katz thick smears and hatching in water) are time-
consuming and have limited sensitivity due to the
day-to-day fluctuations in egg output [13,14]. It must
also be considered that for the Kato-Katz method,
only 41.7 mg of fecal material are examined per slide,
limiting the chance to detect eggs in the case of
light-intensity infections. This results in high rates of
false-negative results in certain populations, most notably
following repeated rounds of mass praziquantel adminis-
tration, the current mainstay of schistosomiasis control
worldwide [15-19]. It follows that the current diagnostic
gold standard may be unsuitable for surveys and surveil-
lance in communities with predominantly low-intensity
infections [20-25].
Immunodiagnostic techniques may be used to de-
tect circulating antigens of schistosomes and to detect
host antibodies against the parasite. However, the im-
munologic diagnosis is usually not species-specific
and may not reliably indicate cure in the short term
[26,27]. Studies showed that the false-positive rates of
the indirect hemagglutination test (IHA) and enzyme
linked immunosorbent assays (ELISA) were very high
in field settings where such tests were used to iden-
tify villagers infected with S. japonicum [28,29]. The-
oretically, the false positives might be stratified into
three groups: 1) infected individuals who were mis-
diagnosed by stool examination; 2) previously infected
individuals who were cured following treatment; 3) cross-
reactions between antigens of/antibodies to other parasites
than S. japonicum. In addition, it has been observed that
immunodiagnostic assays also missed a certain number of
light-intensity infections, especially in areas of relatively
severe endemicity [30].
Okabe & Tanaka [31] arguably were the first ones who
described that antigens secreted by parasites and circu-
lating in the host blood might be a potential diagnostic
material [32,33]. Circulating anodic antigen (CAA) and
circulating cathodic antigen (CCA) are adult worm gut-
associated antigens. Serum levels of CAA are related to
actual worm burden and rapidly decrease following drug
treatment [34-38]. Soluble egg antigens (SEA) of S.
japonicum represent schistosome egg metabolic and
secreted antigens in a patient’s blood, urine or other
body fluids. Detection of SEA thus is a more direct
measure of the presence of worms, providing accurate
information on the status and intensity of infection.
Although the schistosome species currently cannot be
determined based on secreted antigens, the detection
of circulating antigens (SEA, CCA and CAA) has
good specificity for the diagnosis of Schistosoma spp
infections, and there are very few false-positive diag-
noses with these methods [39,40].Methods
Ethics statement
The study was authorized by the ethics committee of IPD,
China CDC (Ref No: 20100802–1). All participants were
informed about the study aims and procedures, following
which they gave written informed consent to participate.
Participants who were found to be parasitologically posi-
tive were given free praziquantel treatment.
Study population
A total of 1864 individuals residing in five administrative
villages in Jiangling county, Hubei province participated
in this study. All participants were aged between 6 and
72 years at the time of the study (August and September
2010). All participants were screened by serum examin-
ation with an indirect hemagglutination assay (IHA,
LOT: 20100608 from Anji Pharmaceutical Science and
Technology Co. Ltd.). Infections were confirmed by
stool examination with the Kato-Katz technique for indi-
viduals with titers ≥20. Each participant was asked to
provide one blood sample of about 2–3 ml collected by
venipuncture, and positive individuals were asked to
provide one stool sample of over 50 g. The samples were
transferred to the local schistosomiasis stations where
IHA and Kato-Katz tests were performed by laboratory
staff within 24 hours of sample collection. All serum
samples of good quality and a volume above 0.5 ml were
selected for further testing. Immunodiagnostic antibody
(DDIA and ELISA) and antigen (ELISA) assays were
performed by trained staff of the National Institute of
Parasitic Diseases, Chinese Center for Disease Control
and Prevention (IPD, China CDC) in Shanghai after the
field work.
Stool examinations
The Kato-Katz thick smear method was used to detect
schistosome eggs in the collected stool samples. Three
slides were prepared per sample, using a standard
template holding 41.7 mg. Each slide was checked by
two experienced technicians 12–48 h after their initial
preparation. Eggs per gram of stool (EPG) was used to
express the infection intensity, calculated as the arith-
metic mean of the egg counts obtained from the three
slides multiplied by 24 [41].
Immunodiagnostic antibody assays – IHA, ELISA and DDIA
Indirect hemagglutination assay (IHA)
The IHA test kits were purchased form the Anhui pro-
vincial Institute of Parasitic Diseases, P.R China. The test
instructions were accurately followed and all sera were
tested by this method. In brief, 100 μl of normal saline
solution was added to the first well of the plate in the
transverse line and 25 μl of normal saline solution were
added to the wells 2 and 3. A total of 25 μl serum was
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the saline solution. In the next step, 25 μL of the mix-
ture in the first well was transferred to the second well
and mixed as before. The same procedure was repeated
for the third well. Hence, the concentration of the sec-
ond well was 1:10 and that of the third well was 1:20.
Positive and negative control sera were tested simultan-
eously on each Plate. 25 μl of 2.5% sensitized red blood
cells was placed into each well, shaken, and kept at 37°C
for half an hour. The results of the test were read by eye.
The terminal point of a positive reaction was the highest
titer where agglutination appeared. If a positive reaction
appeared at a titer 1:10, the sample was considered
positive [42].
ELISA antibody assay
The ELISA test kits for detecting anti-schistosome anti-
bodies were purchased form Shenzhen Combined Biotech
Co., P.R China [43]. The experiments were operated
according to the manufacturer’s instructions. To each well
of the ELISA plate were added 100 μl of the patient serum
(1:100 diluted), and the plate was incubated at 37°C for
half an hour. The plate was then washed 3 times with
washing buffer. 100 μl of a peroxidase-conjugated goat
anti-human IgG antibody was added, and the plate was
incubated again at 37°C for half an hour. After that the
plate was washed, tetramethyl benzidine (TMB) substrate
was added to each well, and the plate was incubated for
10 minutes at 37°C. The reaction was stopped by adding
50 μl of 2 m sulfuric acid to each well. The optical density
(O.D.) was measured at 450 nm.
Dipstick Dye Immunoassay (DDIA)
The serum samples were also tested by the DDIA
method [5], with DDIA kits purchased form Wuxi Saide
Medical Technology Co. Ltd., P.R. China. The tests were
performed according to the instructions supplied by the
manufacturer. In brief, to each polyvinyl chloride (PVC)
well a drop of blue colloidal dye-labeled soluble egg
antigens (SEA) solution was added, followed by 20 μl of
serum. The content of the well was then mixed gently
for one minute, and a dipstick was inserted into the well.Table 1 Prevalence of Schistosoma japonicum according to di
Village Total Kato-Katz method Immunodiagnostic ant
Positive
(number)
Positive (%)
[95% CI]
IHA ELISA DDIA Average
(number)
Village A 544 1 0.2 [0.03-0.33] 30 30 29 29.7
Village B 239 1 0.4 [0.08-0.75] 11 11 11 11
Village C 311 7 2.3 [0.63-4.0] 44 44 44 44
Village D 361 10 2.8 [1.1-4.5] 87 87 81 85
Village E 409 9 2.2 [0.78-3.62] 68 68 66 67.3
Total 1864 28 1.5 [0.95-2.05] 240 240 231 237Ten minutes later, when the solution was absorbed com-
pletely, the result was read by eye. Positive samples had
two blue bands on the control line and the test line of
the dipstick, while a negative one only had one single
blue band on the control line.
ELISA antigen assay
Two ELISA kits were used to detecting circulating
antigens in all serum samples. One was purchased from
Sichuan Maker Biotechnology Co. P.R. China (which
was designed to detecting circulating S. japonicum SEA
antigen in the serum of patients). The second one was a
sandwich ELISA established by our laboratory using a
combination of anti-S. japonicum SEA-IgY polyclonal
antibodies and anti-S. japonicum SEA-IgM monoclonal
antibodies. The specificity of the sandwich ELISA for
detecting circulating S. japonicum SEA antigen in the
serum of infected individuals has been established [44].
The steps involved in testing a sample with the two kits
were basically the same as described for the ELISA anti-
body assay. The main difference was that each well of
the commercial ELISA was loaded with 50 μl serum dir-
ectly, while the ELISA developed by our lab required
100 μl serum solution in each well (1:5 diluted).
Statistical analysis
Groups were compared by the Chi-square test or Fisher’s
exact test as appropriate. Differences were considered
significant when the P-value was less than 0.05. 95% confi-
dence intervals (CIs) to the prevalence values of each
method were also calculated.
Results
The sero-prevalence of Schistosoma japonicum according
to different methods
Among the 1864 individual sera, 240 were antibody
positive as tested with the IHA method in the field im-
mediately after the serum samples were collected. This
translates into an average antibody positive rate across
the five villages of 12.7%. The ELISA method gave the
same results as the IHA but the number of positive
samples according to the DDIA method was a littlefferent diagnostic methods
ibody assay Immunodiagnostic antigen assay
Average (%)
[95% CI]
ELISA
(COM)
ELISA
(IgY)
Average
(number)
Average (%)
[95% CI]
5.5 [3.58-7.42] 15 14 14.5 2.7 [1.34-4.06]
4.6 [1.94-7.26] 1 1 1 0.4 [0.08-0.75]
14.1 [10.23-17.97] 18 15 16.5 5.3 [2.81-7.79]
23.5 [19.13-27.87] 34 30 32 8.9 [5.96-11.84]
16.5 [12.90-20.10] 19 21 20 4.9 [2.81-6.99]
12.7 [11.19-14.21] 87 81 84 4.5 [3.56-5.44]
Table 2 Key characteristics of six different diagnostic methods
Assay Tested
samples
Positive
samples
Adjusted prevalence
(%) [95% CI]
Detection
target
Solid phase Time required
per sample
Volume
of sample
Extra
supplies*
IHA 1864 240 12.9 [11.38-14.42] Anti-SEA antibody Red blood cells from sheep 40 min 25 μl Yes
ELISA 1864 240 12.9 [11.38-14.42] Anti-SEA antibody Microtitre plate 90 min 1 μl Yes
DDIA 1864 231 12.4 [10.90-14.90] Anti-SEA antibody Nitrocellulose membrane 15 min 10 μl No
ELISA (COM) 1864 87 4.7 [3.74-5.66] Circulating antigen Microtitre plate 90 min 50 μl Yes
ELISA (IgY) 1864 81 4.3 [3.40-5.22] Circulating antigen Microtitre plate 90 min 20 μl Yes
Kato-Katz 1864 28 1.5 Egg Plastic template 40 min 41.7 mg Yes
*Additional equipment required for all serological tests consisted of handheld micropipettes and micropipette tips.
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for antigens produced by the parasite, average positive
rates of respectively 4.7% (ELISA (COM)) and 4.3%
(ELISA (IgY)) were recorded. Among the 240 fecal sam-
ples from IHA positive participants, S. japonicum eggs
were detected in 28 with the Kato-Katz method. Thus,
the average parasitological prevalence in the five villages
was 1.50% (Table 1).
Major features and statistical comparison of the six
different diagnostic methods
Major features of the diagnostic tests are listed in
Table 2. The three immunodiagnostic antibody assays
(IHA, DDIA and ELISA) were all developed in P.R.
China and met the national criteria for field use. The anti-
gen used for all tests was a crude soluble S. japonicum egg
extract and the specimen tested in all kits was serum.
However, the sample volume differed between assays: an
ELISA test needs just 1 μl serum whereas the IHA assay
and the DDIA assay need 25 μl and 10 μl, respectively.
The two immunodiagnostic antigen assays were both
ELISA tests. The Kato-Katz method was the only parasito-
logical method we used in this study. Significant differ-
ences were observed between the prevalence according to
the Kato-Katz method and all the five immunodiagnostic
assays (Figure 1 and Table 3).Figure 1 S. Japonicum prevalence according to six different test systeDetection of antibodies or antigen in S. japonicum
egg-positive patients
The 28 S. japonicum egg-positive individuals include 7
(25%) women and 21 (75%) men. The median age was
54 years, with a range of 30 to 72 years. Twenty (71.4%)
of the egg positive individuals were farmers, and 8
(28.6%) individuals had other occupations. The EPG
values ranged between 8 and 736, with 10.7% having
≥100 EPG, 21.4% having 50–100 EPG and 67.9% having
≤50 EPG. No co-infection with other helminths was
detected in the 28 samples. The rate of positive results
for each immunological antibody and antigen test of the
28 parasitological positive samples is detailed in Table 4.
The three antibody tests correctly diagnosed 100.0% of
the egg-positive individuals while the two antigen tests
detected 93.0% (ELISA (COM)) and 86% (ELISA (IgY))
of the cases. However, this difference was not statistically
significant (P > 0.05). The 4 false negative specimens
were mostly from patients with EPG values of 24 or less.
Discussion
The prevention and control of schistosomiasis japonica
in P.R. China still faces serious challenges, and accurate
diagnosis is crucial for the effective control and surveil-
lance of the disease. According to the latest national epi-
demiological sampling survey, the average prevalence
was 5.1% in the areas where control of schistosomiasisms.
Table 3 Statistical comparison of the results from six different methods to diagnose S. japonicum infections (P values)
Type Circulating antibody assays Circulating antigen assays Parasitological method
IHA ELISA DDIA ELISA-COM ELISA-IgY Kato-Katz
Circulating antibody assays IHA
ELISA 1
DDIA 0.0495* 0.0495*
Circulating antigen assays ELISA-COM <0.0001** <0.0001** <0.0001**
ELISA-IgY <0.0001** <0.0001** <0.0001** 0.0833
Parasitological method Kato-Katz <0.0001** <0.0001** <0.0001** <0.0001** <0.0001**
*indicates significant difference (p < 0.05);**indicates highly significant difference (p < 0.001).
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surveyed endemic areas the average prevalence was 2.5%
[45]. To achieve the ultimate goal of elimination, a
national program was established with the aim of decreas-
ing the prevalence of schistosome infection in all endemic
counties below 5% in 2008 and 1% in 2015 [46,47]. The
study region in Jiangling county is a hyper-endemic area
of S. japonicum in accordance with the current national
prevalence classification. The five villages can be divided
into two different levels, village A and B where the average
prevalence is 0.3% according to the gold standard (Kato-
Katz method), much lower than in the villages C, D and E
where the prevalence was 2.4%.
Serological diagnosis of anti-schistosome antibodies
has been widely used in endemic areas because it is
more sensitive than parasitological diagnosis and anti-
bodies are easier to detect than antigens [43]. In this
study, we used three circulating antibody detection
methods, IHA, ELISA and DDIA. They demonstrated a
good ability to identify schistosomiasis patients, with
positive rates in the range of 12.9%, 12.9% and 12.4%.
The IHA and ELISA gave the same results. The antibody
ELISA can give quantitative results based on OD values,
but the need for a 37°C incubator and a microplate
reader to obtain results limits its use. IHA tests are the
most widely used assays in P.R. China and only need an
incubator. The DDIA method gave the lowest number of
positive results but has its own advantages: the time
required per sample of DDIA is only 15 min, no extra sup-
plies are needed and it is suitable for large-scale screen-
ings. Despite the advantages of these methods, detection
of circulating antibodies also has its disadvantages asTable 4 Detection of antibodies or antigen in S. japonicum eg
Assay No. of positives No. of false negatives EPG* f
IHA 28 0
ELISA 28 0
DDIA 28 0
ELISA(COM) 26 2
ELISA(IgY) 24 4
*EPG: egg per gram feces.detecting antibodies cannot distinguish between current
and past infections. Evaluating treatment outcomes is thus
impossible, as antibodies are retained in the body for a
number of years after treatment [9,48].
Conversely, detection of parasite antigen may indicate
the existence of active infection, and can greatly reduce
the rate of false-positive results compared to antibody
detection tests. This reduces costs of field investigations
while improving accuracy of diagnosis. The reduced sam-
ple size required for surveillance and improved targeting
of infected individuals with this method are particularly
welcome as after years and years of praziquantel che-
motherapy, treatment compliance in endemic areas is
worsening [49,50]. In this study, two antigen detection
methods had been evaluated. The prevalence according
to the two methods were 4.3% (ELISA (IgY)) and
4.7% (ELISA (COM)). There were no significant differ-
ences between the two methods (P = 0.083). The average
prevalence according to the two antigen-detecting
methods was 4.5%, higher than with the parasitological
method (1.5%), and lower than with the antibody-
detecting methods (12.7%). The reason probably is that
the fraction of truly infected individuals that tested posi-
tive in stool examinations was very low [51,52], resulting
in many false-negative diagnoses [53-55]. Antigen detec-
tion methods may more accurately reflect the existence of
active infections in the population, and allow the evalu-
ation of treatment outcomes. However, antigen detection
ELISA methods are not a complete solution as we found
that among the 28 serum samples from egg-positive indi-
viduals, antigens were detected only in 24 samples while 4
samples tested negative (these being subjects with EPGg-positive patients (n = 28)
or misdiagnosed Sensitivity (%) P value against Kato-Katz
0 100% 1
0 100% 1
0 100% 1
8,8 93% 0.48
24,8,8,8 86% 0.13
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is the “gold standard” for the detection of schistosomiasis
and that all individuals with a positive stool examination
finding were truly infected with S. japonicum, antigen
detection would have a sensitivity of 89.3% (25/28). The
following points are offered for consideration. 1. There is
a problem with false-negative results in ELISA kits for
antigen detection; 2. There is no linear relationship
between the concentration of circulating antigens in the
patient’s body and the number of S. japonicum eggs in the
patient’s stools as the concentration of circulating antigens
is influenced by many other factors, such as the health
condition and immune status of the patient, or the forma-
tion of circulating immune complexes which are difficult
to detect [56].
Both the immunodiagnostic antibody assays (IHA,
ELISA and DDIA), and the immunodiagnostic antigen
assays (ELISA (IgY) and ELISA (COM)) need collection
of whole blood samples via venipuncture. This is a limi-
tation because well trained personnel are required and
the practice is not always widely accepted by the popu-
lation. In recent years, based on the observation that
parasite antigens may indicate the existence of an active
infection, and its detection can greatly reduce the false-
positive rate of antibody detection tests, immunodiagnostic
antigen assays (SEA, CCA and CAA) have been heralded
as ideal diagnostic tests, and a number of circulating anti-
gen assays have been developed to detect Schistosoma
japonicum or Schistosoma mansoni infections [57-60]. A
rapid diagnostic test has also been developed to detect cir-
culating cathodic antigen (CCA) of Schistosoma mansoni
in urine [61]. In our study we chose to only focus on schis-
tosome egg antigen, and not CCA or CAA. Schistosomiasis
japonica is different from the other three schistosome
species in that in the chronic stage, patients may develop
liver fibrosis, also called schistosome egg-induced fibrosis,
indicating that eggs play an important role in the develop-
ment of the pathology. So though CCA and CAA have the
advantage of being antigens directly associated with adult
worm feeding, SEA is expected to be more indicative of
an active infection than CCA or CAA in the chronic and
later stage. The sandwich ELISA developed in our labora-
tory using a combination of anti-S. japonicum SEA-IgY
polyclonal antibodies and anti-S. japonicum SEA-IgM
monoclonal antibodies (ELISA (IgY)) gave almost the
same results as the ELISA (COM)) assay which is wildly
used in P.R. China. In conclusion, we believe that immu-
nodiagnostic techniques to detect circulating antigens
have the potential to be deployed for schistosomiasis
japonica screening in the endemic areas.
Conclusions
Our study confirmed that both circulating antibody and
circulating antigen assays had acceptable performancecharacteristics. But significant differences were ob-
served between the antigen and antibody assays (P-
value <0.0001).The sandwich ELISA developed in our
laboratory for detecting circulating antigen gave great
results in this study, so we believe immunodiagnostic
techniques to detect circulating antigens have potential to
be deployed for schistosomiasis japonica screening in the
endemic areas.
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